Taylor Merry - Concepedia

Author

Taylor Merry

Ariadne Diagnostics (United States)

Also Known As

Taylor J. Merry, Taylor Merry

Publications

378

Citations

H-Index

Concepts

All Affiliations

Ariadne Diagnostics (United States)

About

Taylor Merry is an author at Ariadne Diagnostics (United States) specializing in drug discovery, chemical biology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	358
2	Natural Sciences	6	6	335
3	Biochemistry	6	6	317
4	Biomolecular Engineering	2	2	56
5	Engineering	1	1	19

Taylor Merry

Publications

377

Citations

H-Index

Page 1

	Year	Citations
Structure-based design of an osteoclast-selective, nonpeptide Src homology 2 inhibitor with <i>in vivo</i> antiresorptive activity William C. Shakespeare, Michael G. Yang, Regine S. Bohacek, Proceedings of the National Academy of Sciences Medicinal ChemistrySclerostinBiochemistryBone Morphogenic ProteinNatural Sciences	2000	133
Discovery of Potent and Selective SH2 Inhibitors of the Tyrosine Kinase ZAP-70 Chi B. Vu, Evelyn G. Corpuz, Taylor Merry, Journal of Medicinal Chemistry Medicinal ChemistryDrug TargetBiochemistryTyrosine Kinase Zap-70Medicine	1999	88
Structure-activity relationships of a novel class of Src SH2 inhibitors John L. Buchanan, Chi B. Vu, Taylor Merry, Bioorganic & Medicinal Chemistry Letters Molecular DockingBiochemistryMedicineNatural SciencesRational Drug Design	1999	38
X-ray Structure of Citrate Bound to Src SH2 Leads to a High-Affinity, Bone-Targeted Src SH2 Inhibitor Regine S. Bohacek, David C. Dalgarno, Marcos Hatada, Journal of Medicinal Chemistry Crystal StructureDrug TargetSrc Sh2 LeadsMolecular BiologyPharmacotherapy	2001	37
Bone-Targeted pyrido[2,3-d]pyrimidin-7-ones: potent inhibitors of Src tyrosine kinase as novel antiresorptive agents Chi B. Vu, George P. Luke, Noriyuki Kawahata, Bioorganic & Medicinal Chemistry Letters SclerostinMedicineSrc Tyrosine KinaseAnti-cancer AgentPotent Inhibitors	2003	23
A novel phosphotyrosine mimetic 4′-carboxymethyloxy-3′-phosphonophenylalanine (cpp): exploitation in the design of nonpeptide inhibitors of pp60Src SH2 domain Noriyuki Kawahata, Michael G. Yang, George P. Luke, Bioorganic & Medicinal Chemistry Letters BiochemistryMedicineNatural SciencesRational Drug DesignPp60src Sh2 Domain	2001	21
Novel phosphate ester-linked resins: The solid-phase generation of phenyl phosphate-containing compounds for SH2 inhibition Chester A. Metcalf, Chi B. Vu, Raji Sundaramoorthi, Tetrahedron Letters Solid-phase GenerationEngineeringBiochemistryOrganic ChemistryPhenyl Phosphate-containing Compounds	1998	19
Structure‐based design of novel nonpeptide inhibitors of the Src SH2 domain: Phosphotyrosine mimetics exploiting multifunctional group replacement chemistry* Raji Sundaramoorthi, Noriyuki Kawahata, Michael G. Yang, Biopolymers Combinatorial ChemistryMedicinal ChemistryBiochemistryPhosphotyrosine MimeticsNatural Sciences	2003	18

Page 1